SCHEMBL29596279

SCHEMBL29596279

CCOc1cccc(C(=O)Nc2ncc(Cl)nc2Nc2c(OC)cccc2OC)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 2/20 0.42
GRM5 P41594 2/20 0.40
MAPK8 P45983 1/20 0.40
CBLB Q13191 1/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
MAPT P10636 1/20 0.37
PABPC1 P11940 1/20 0.36
GRM4 Q14833 1/20 0.36
KCNK3 O14649 1/20 0.36
KCNK9 Q9NPC2 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
KDM4E B2RXH2 3/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21826883 1.00 APLNR (0.42) APLNRGRM5MAPK8CBLBMEN1
SCHEMBL21827569 0.96 APLNR (0.42) APLNRGRM5MAPK8CBLBMEN1
SCHEMBL31471124 0.96 APLNR (0.42) APLNRGRM5MAPK8CBLBMEN1
SCHEMBL25537829 0.94 APLNR (0.39) APLNRGRM5MAPK8CBLBMEN1
SCHEMBL21826857 0.91 CCR4 (0.39) APLNRGRM5MAPK8MEN1KMT2A
SCHEMBL21827065 0.89 APLNR (0.43) APLNRGRM5MAPK8CBLBMEN1
SCHEMBL31471101 0.89 APLNR (0.43) APLNRGRM5MAPK8CBLBMEN1
SCHEMBL31471113 0.87 APLNR (0.40) APLNRMEN1KMT2AGRM4KDM4E
SCHEMBL21827107 0.87 APLNR (0.40) APLNRMEN1KMT2AGRM4KDM4E
SCHEMBL31471102 0.86 APLNR (0.42) APLNRGRM5MAPK8CBLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113490668-B Compounds and compositions for the treatment of diseases associated with APJ receptor activity 安娜普尔纳生物股份有限公司 2025-02-25 CN disclosed
US-11471455-B2 Compounds and compositions for treating conditions associated with APJ receptor activity ANNAPURNA BIO, INC. (US) 2022-10-18 US disclosed
US-20220125787-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY ANNAPURNA BIO, INC. 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220125787-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY APLNR, AGTR1, AGTR2 APLNR 1/4885GRM5 446/4885MAPK8 621/4885
US-11471455-B2 Compounds and compositions for treating conditions associated with APJ receptor activity APLNR, AGTR1, AGTR2 APLNR 1/4885GRM5 435/4885MAPK8 624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.